cypath lung

SAN ANTONIO, September 1, 2026 bioAffinity Technologies, Inc. is advancing the potential use of its noninvasive CyPath® Lung test...

SAN ANTONIO, Texas, August 7, 2026 bioAffinity Technologies reported second quarter 2026 financial results highlighted by continued commercial momentum...

SAN ANTONIO, July 27, 2026 bioAffinity Technologies, Inc. announced the publication of a comprehensive clinical review and white paper...

SAN ANTONIO, Texas, United States, April 7, 2026 bioAffinity Technologies, Inc. announced that its CyPath® Lung diagnostic test will...

SAN ANTONIO, TX, March 17, 2026 bioAffinity Technologies, Inc. has released a new clinical case study demonstrating how its...